Rita Balice-Gordon
Director/Board Member at COLLEGIUM PHARMACEUTICAL, INC.
Net worth: 1 M $ as of 2024-02-28
Profile
Currently, Rita Balice-Gordon is Chief Executive Officer & Director at Muna Therapeutics ApS.
She is also on the board of Collegium Pharmaceutical, Inc. and Capsida Biotherapeutics, Inc.
In her past career she held the position of President-Neuroscience & Pain Research Unit at Pfizer Inc., Global Head-Rare & Neurological Diseases at Sanofi, Inc. and Professor at Perelman School of Medicine.
She received an undergraduate degree from Northwestern University and a doctorate from The University of Texas at Austin.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-05-17 | 38,795 ( 0.12% ) | 1 M $ | 2024-02-28 |
Rita Balice-Gordon active positions
Companies | Position | Start |
---|---|---|
COLLEGIUM PHARMACEUTICAL, INC. | Director/Board Member | 2020-09-23 |
Muna Therapeutics ApS
Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Chief Executive Officer | - |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Director/Board Member | 2021-05-11 |
Former positions of Rita Balice-Gordon
Companies | Position | End |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - |
Perelman School of Medicine | Corporate Officer/Principal | - |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a private company based in New York, NY. | Corporate Officer/Principal | - |
Training of Rita Balice-Gordon
Northwestern University | Undergraduate Degree |
The University of Texas at Austin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PFIZER, INC. | Health Technology |
COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
Private companies | 3 |
---|---|
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a private company based in New York, NY. | Retail Trade |
Muna Therapeutics ApS
Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Health Services |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Commercial Services |